With all the recent discussion and debate by the presidential candidates regarding healthcare issues, I thought a study published last month in CA: A Cancer Journal for Clinicians was quite timely. The study, titled Association of Insurance with Cancer Care Utilization and Outcomes, presents evidence that lack of adequate health insurance coverage is associated with reduced access to care and poorer outcomes for cancer patients [1]. The article further presents data on the association between health insurance status and screening, stage at diagnosis and survival for breast and colorectal cancer.
Biodegradable Polymers for Drug and Gene Delivery
In participation with Blog Action Day, an event where bloggers from around the world unite to put a single important issue on everyone’s mind – the environment – today’s article discusses recent advances in the use of biodegradable materials for drug and gene delivery.
Treating Cancer with Personalized Medicine
A Michigan oncologist recently devised a simple experiment to help treat seven patients with advanced, incurable cancer. The experiment used DNA microarray technology to analyze each patient’s tumors for the expression of genes associated with positive response to anti-cancer drugs. The oncologist, Dr. Eric Lester, M.D., then based his drug treatment plans on the results. Four of seven patients are reported to have had a better outcome than expected [1].
Although every cell in the body contains identical genetic material, the same genes are not active in every cell. Tumor cells are no exception. Cancer refers to any one of a large number of diseases characterized by abnormal cell growth and proliferation. Few of these diseases can be treated in the same way, since the genes responsible for a variety of biological processes — DNA duplication, cellular proliferation, cell death — are different from one tumor to the next.
SCHIP Funding and Fiscal Irresponsibility
$60 billion dollars in new deficit spending.
That’s the amount the Heritage Foundation, a public policy research institute based in Washington D.C., estimates the Senate bill to reauthorize the State Children’s Health Insurance Program (SCHIP) will have added to the U.S. budget deficit over the next decade [1-2]. Under the bill, funding will drop sharply in 2013 (see the graph below). Assuming a 6% annual spending increase will be required to maintain current enrollment from 2012-2017, the program will require $84.3 billion rather than the $25.6 billion included in the bill.
The House bill has an even greater cost. According to the Congressional Budget Office (CBO) and the Joint Committee on Taxation (JCT), the U.S. House of of Representatives SCHIP bill would add $72.9 billion dollars to the U.S. budget deficit for the 2008-2017 period [3].